{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T13:05:41Z","timestamp":1780578341765,"version":"3.54.1"},"reference-count":32,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:00:00Z","timestamp":1780531200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>Background and Clinical Significance: SWI\/SNF chromatin remodeling complex-deficient malignancies constitute an aggressive group of undifferentiated tumors defined by inactivation of core subunits including SMARCA4 (BRG1) or SMARCB1 (INI1). In the head and neck, these tumors predominate in the sinonasal tract; oral cavity presentations are exceedingly rare, with reported cases predominantly representing metastatic disease. Peri-implant gingival masses in clinical practice are overwhelmingly reactive, but their occasional malignant nature mandates timely biopsy and thorough pathologic workup. We report the first comprehensively molecularly characterized case of a peri-implant gingival SWI\/SNF complex-deficient tumor with confirmed biallelic SMARCA4 inactivation. Case Presentation: A 75-year-old man presented with a one-week history of a rapidly enlarging exophytic erythematous peri-implant gingival mass in the right posterior mandible (region 44\u201347). Incisional biopsy demonstrated an undifferentiated high-grade tumor with epithelioid, plasmablastoid, and focally rhabdoid morphology with necrosis. Immunohistochemistry showed complete loss of BRG1 (SMARCA4) with retained INI1 (SMARCB1), EMA positivity, Ki-67 of approximately 100%, and negativity across all lineage-specific markers (hematolymphoid, epithelial, melanocytic, endothelial, squamous). Comprehensive next-generation sequencing (Oncomine Comprehensive Assay Plus) confirmed biallelic SMARCA4 inactivation via a truncating nonsense mutation (p.Trp1346Ter; VAF 73.85%) combined with copy number loss, establishing the molecular mechanism underlying BRG1 protein loss. Co-occurring alterations included homozygous CDKN2A\/CDKN2B deletion, MTAP loss (9p21.3), clonal TP53 and KEAP1 mutations, and intermediate\u2013high tumor mutational burden (13.3 mutations\/Mb) with microsatellite stability. The patient initiated carboplatin\u2013paclitaxel and achieved a partial response at one month with further shrinkage by four months. This case illustrates a rare oral cavity manifestation of SWI\/SNF complex deficiency arising in a peri-implant location, with a diagnostic workup that required integration of immunohistochemistry and molecular profiling for definitive characterization. The MTAP deletion co-occurring with homozygous CDKN2A\/B loss identifies a potentially actionable synthetic lethal vulnerability to MAT2A and PRMT5 inhibitors currently under clinical investigation. An occult primary site could not be fully excluded due to absence of a dedicated staging workup. Conclusions: Rapidly enlarging peri-implant gingival masses should prompt timely biopsy and SWI\/SNF marker testing when histology is high-grade and lineage-ambiguous. NGS-based molecular profiling confirms diagnosis, elucidates mechanism, and reveals actionable targets in this rare tumor class.<\/jats:p>","DOI":"10.3390\/diagnostics16111732","type":"journal-article","created":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T11:52:30Z","timestamp":1780573950000},"page":"1732","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Peri-Implant Gingival Undifferentiated SWI\/SNF Complex-Deficient Tumor with Molecularly Confirmed Biallelic SMARCA4 Inactivation: Diagnostic Pitfalls and Genomic Characterization"],"prefix":"10.3390","volume":"16","author":[{"given":"Haim","family":"Ohayon","sequence":"first","affiliation":[{"name":"Department of Oral and Maxillofacial Surgery, Rambam Health Care Campus, Haifa 3109601, Israel"},{"name":"The Ruth & Bruce Rappaport Faculty of Medicine, Technion\u2013Israel Institute of Technology, Haifa 3109601, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7490-0501","authenticated-orcid":false,"given":"Ahmad","family":"Hija","sequence":"additional","affiliation":[{"name":"Department of Oral and Maxillofacial Surgery, Rambam Health Care Campus, Haifa 3109601, Israel"},{"name":"The Ruth & Bruce Rappaport Faculty of Medicine, Technion\u2013Israel Institute of Technology, Haifa 3109601, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Bilder","sequence":"additional","affiliation":[{"name":"Department of Oral and Maxillofacial Surgery, Rambam Health Care Campus, Haifa 3109601, Israel"},{"name":"The Ruth & Bruce Rappaport Faculty of Medicine, Technion\u2013Israel Institute of Technology, Haifa 3109601, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tal","family":"Capucha","sequence":"additional","affiliation":[{"name":"Department of Oral and Maxillofacial Surgery, Rambam Health Care Campus, Haifa 3109601, Israel"},{"name":"The Ruth & Bruce Rappaport Faculty of Medicine, Technion\u2013Israel Institute of Technology, Haifa 3109601, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Akrish","sequence":"additional","affiliation":[{"name":"Department of Oral and Maxillofacial Surgery, Rambam Health Care Campus, Haifa 3109601, Israel"},{"name":"The Ruth & Bruce Rappaport Faculty of Medicine, Technion\u2013Israel Institute of Technology, Haifa 3109601, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Wolff","sequence":"additional","affiliation":[{"name":"Department of Oral and Maxillofacial Surgery, Rambam Health Care Campus, Haifa 3109601, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omri","family":"Emodi","sequence":"additional","affiliation":[{"name":"Department of Oral and Maxillofacial Surgery, Rambam Health Care Campus, Haifa 3109601, Israel"},{"name":"The Ruth & Bruce Rappaport Faculty of Medicine, Technion\u2013Israel Institute of Technology, Haifa 3109601, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,6,4]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"e1500447","DOI":"10.1126\/sciadv.1500447","article-title":"Mammalian SWI\/SNF chromatin remodeling complexes and cancer: Mechanistic insights gained from human genomics","volume":"1","author":"Kadoch","year":"2015","journal-title":"Sci. Adv."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Shain, A.H., and Pollack, J.R. (2013). The spectrum of SWI\/SNF mutations, ubiquitous in human cancers. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0055119"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1053\/j.semdp.2021.02.002","article-title":"SWI\/SNF-deficient head and neck neoplasms: An overview","volume":"38","author":"Agaimy","year":"2021","journal-title":"Semin. Diagn. Pathol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1007\/s12105-022-01416-x","article-title":"SWI\/SNF-deficient Sinonasal Neoplasms: An Overview","volume":"16","author":"Agaimy","year":"2022","journal-title":"Head Neck Pathol."},{"key":"ref_5","first-page":"104","article-title":"SWI\/SNF-deficient Sinonasal Carcinomas","volume":"40","author":"Agaimy","year":"2023","journal-title":"Semin. Diagn. Pathol."},{"key":"ref_6","unstructured":"WHO Classification of Tumours Editorial Board (2022). Head and Neck Tumours: WHO Classification of Tumours, IARC. [5th ed.]."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1038\/ng.3399","article-title":"SMARCA4 inactivation defines a group of undifferentiated thoracic malignancies transcriptionally related to BAF-deficient sarcomas","volume":"47","author":"Watson","year":"2015","journal-title":"Nat. Genet."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jtho.2019.10.023","article-title":"SMARCA4-Deficient Thoracic Sarcomatoid Neoplasms Represent Primarily Smoking-Related Undifferentiated Carcinomas Rather Than Primary Thoracic Sarcomas","volume":"15","author":"Rekhtman","year":"2020","journal-title":"J. Thorac. Oncol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/modpathol.2015.155","article-title":"Loss of switch\/sucrose non-fermenting complex protein expression is associated with dedifferentiation in endometrial carcinomas","volume":"29","author":"Karnezis","year":"2016","journal-title":"Mod. Pathol."},{"key":"ref_10","unstructured":"WHO Classification of Tumours Editorial Board (2020). Soft Tissue and Bone Tumours: WHO Classification of Tumours, IARC. [5th ed.]."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.5858\/arpa.2021-0001-OA","article-title":"SMARCA4\/BRG1-Deficient Sinonasal Carcinoma","volume":"146","author":"Kakkar","year":"2022","journal-title":"Arch. Pathol. Lab. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1097\/PAS.0000000000001428","article-title":"SMARCA4-deficient Sinonasal Carcinoma: A Series of 10 Cases Expanding the Genetic Spectrum of SWI\/SNF-driven Sinonasal Malignancies","volume":"44","author":"Agaimy","year":"2020","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1097\/PAS.0000000000000797","article-title":"SMARCB1(INI-1)-deficient Sinonasal Carcinoma: A Series of 39 Cases Expanding the Morphologic and Clinicopathologic Spectrum of a Recently Described Entity","volume":"41","author":"Agaimy","year":"2017","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1053\/j.semdp.2015.12.001","article-title":"Recently described neoplasms of the sinonasal tract","volume":"33","author":"Bishop","year":"2016","journal-title":"Semin. Diagn. Pathol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s12105-017-0783-4","article-title":"SMARCA4-deficient Sinonasal Carcinoma","volume":"11","author":"Agaimy","year":"2017","journal-title":"Head Neck Pathol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/bs.acr.2016.04.001","article-title":"Small molecule targeting of BET proteins in cancer","volume":"131","author":"French","year":"2016","journal-title":"Adv. Cancer Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1097\/PAS.0000000000001046","article-title":"NUT carcinoma of the salivary glands: Clinicopathological and molecular analysis of 3 cases and a survey of NUT expression in salivary gland carcinomas","volume":"42","author":"Agaimy","year":"2018","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s12105-024-01614-9","article-title":"Primary Oropharyngeal SMARCA4-Deficient Carcinoma: Expanding the Diagnostic Spectrum in Head and Neck Cancer","volume":"18","author":"Pasricha","year":"2024","journal-title":"Head Neck Pathol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s12105-025-01819-6","article-title":"Metastatic SMARCA4-Deficient Undifferentiated Carcinoma of the Oral Cavity: A Case Report and Review of Literature","volume":"19","author":"Kim","year":"2025","journal-title":"Head Neck Pathol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1126\/science.aad5944","article-title":"Disordered methionine metabolism in MTAP\/CDKN2A-deleted cancers leads to dependence on PRMT5","volume":"351","author":"Mavrakis","year":"2016","journal-title":"Science"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1126\/science.aad5214","article-title":"MTAP deletion confers enhanced dependency on the PRMT5 arginine methyltransferase in cancer cells","volume":"351","author":"Kryukov","year":"2016","journal-title":"Science"},{"key":"ref_22","first-page":"1968","article-title":"SMARCA4-deficient thoracic undifferentiated tumor: A clinical and molecular analysis","volume":"16","author":"Tlemsani","year":"2021","journal-title":"J. Thorac. Oncol."},{"key":"ref_23","first-page":"3002","article-title":"Genomic alterations in SWI\/SNF-deficient undifferentiated\/rhabdoid carcinomas and their therapeutic implications","volume":"15","author":"Yokoyama","year":"2023","journal-title":"Cancers"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/ID.0b013e3181676059","article-title":"Implant success, survival, and failure: The International Congress of Oral Implantologists (ICOI) Pisa Consensus Conference","volume":"17","author":"Misch","year":"2008","journal-title":"Implant Dent."},{"key":"ref_25","first-page":"501","article-title":"Peri-implant squamous cell carcinoma: A growing concern","volume":"42","author":"Mehta","year":"2016","journal-title":"J. Oral Implantol."},{"key":"ref_26","first-page":"485","article-title":"Oral squamous cell carcinoma around dental implants: A systematic review","volume":"51","author":"Mello","year":"2022","journal-title":"Int. J. Oral Maxillofac. Surg."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e24669","DOI":"10.1097\/MD.0000000000024669","article-title":"18F-FDG PET\/CT for detection of primary tumor in squamous cell carcinoma of unknown primary: A systematic review and meta-analysis","volume":"100","author":"Chen","year":"2021","journal-title":"Medicine"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"e2024009","DOI":"10.4084\/MJHID.2024.015","article-title":"Plasmablastic Lymphoma. A State-of-the-Art Review: Part 1","volume":"16","author":"Bibas","year":"2024","journal-title":"Mediterr. J. Hematol. Infect. Dis."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s13000-015-0315-z","article-title":"Clinicopathologic features of plasmablastic lymphoma: Single-center series of 8 cases from Saudi Arabia and review of the literature","volume":"10","author":"Elyamany","year":"2015","journal-title":"Diagn. Pathol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"643","DOI":"10.5858\/arpa.2021-0462-OA","article-title":"CD138-Negative Plasmablastic Lymphoma: A Multi-institutional Study and Review of the Literature","volume":"147","author":"Choudhuri","year":"2023","journal-title":"Arch. Pathol. Lab. Med."},{"key":"ref_31","first-page":"217","article-title":"Plasmablastic lymphoma: Our 10-year experience","volume":"11","author":"Castillo","year":"2018","journal-title":"Expert Rev. Hematol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1097\/PAS.0000000000000554","article-title":"SWI\/SNF complex-deficient undifferentiated\/rhabdoid carcinomas of the gastrointestinal tract: A series of 13 cases highlighting mutually exclusive loss of SMARCA4 and SMARCA2 and frequent co-inactivation of SMARCB1 and SMARCA2","volume":"40","author":"Agaimy","year":"2016","journal-title":"Am. J. Surg. Pathol."}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/16\/11\/1732\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T12:12:32Z","timestamp":1780575152000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/16\/11\/1732"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,4]]},"references-count":32,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["diagnostics16111732"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics16111732","relation":{},"ISSN":["2075-4418"],"issn-type":[{"value":"2075-4418","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,4]]}}}